Kyverna Therapeutics, Inc.

of this Current Report, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 8,

Financial Statements and Exhibits. (d) Exhibits Number Description 10.1 Employment Offer Letter, dated January 9, 2026, between Kyverna Therapeutics, Inc. and C